Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4D | Q6B0I6 | 1/20 | 0.53 |
| ▸ | PRSS1 | P07477 | 8/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | F2 | P00734 | 2/20 | 0.46 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.46 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.46 |
| ▸ | TMPRSS6 | Q8IU80 | 2/20 | 0.46 |
| ▸ | ST14 | Q9Y5Y6 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | MITF | O75030 | 1/20 | 0.44 |
| ▸ | FNTA | P49354 | 1/20 | 0.44 |
| ▸ | FNTB | P49356 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11175449 | 0.93 | PRSS1 (0.51) | KDM4DPRSS1F2PRSS2PRSS3 | |
| SCHEMBL11174529 | 0.93 | PRSS1 (0.51) | KDM4DPRSS1F2PRSS2PRSS3 | |
| SCHEMBL11184370 | 0.91 | PRSS1 (0.50) | KDM4DPRSS1F2PRSS2PRSS3 | |
| SCHEMBL11183424 | 0.91 | PRSS1 (0.50) | KDM4DPRSS1F2PRSS2PRSS3 | |
| SCHEMBL19959711 | 0.90 | TRPA1 (0.56) | KDM4DPRSS1F2PRSS2PRSS3 | |
| SCHEMBL11748691 | 0.90 | PRSS1 (0.57) | PRSS1TP53TSHRF2PRSS2 | |
| Benzoic Acid SCHEMBL27857697 | 0.89 | ALDH1A1 (0.55) | KDM4DTSHRPOLBALDH1A1MAPT | |
| SCHEMBL1663499 | 0.88 | TSHR (0.50) | TP53TSHRPOLBMITFFNTA | |
| SCHEMBL29722205 | 0.83 | ALDH1A1 (0.55) | PRSS1F2PRSS2PRSS3TMPRSS6 | |
| SCHEMBL11176612 | 0.83 | ALDH1A1 (0.57) | PRSS1TSHRF2PRSS2PRSS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3184448-B1 | MULTILAYER PLASTIC CONTAINER | MITSUBISHI GAS CHEMICAL CO (JP) | 2019-04-03 | — | — | EP | disclosed |
| US-20170267436-A1 | MULTILAYER PLASTIC CONTAINER | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2017-09-21 | — | — | US | disclosed |
| EP-3184448-A1 | MULTILAYER PLASTIC CONTAINER | Mitsubishi Gas Chemical Company, Inc. (JP) | 2017-06-28 | — | — | EP | disclosed |
| US-9622991-B2 | Hematopoietic growth factor mimetic small molecule compounds and their uses | LIGAND PHARMACEUTICALS INC. (US) | 2017-04-18 | — | — | US | disclosed |
| US-9144557-B2 | Hematopoietic growth factor mimetic small molecule compounds and their uses | LIGAND PHARMACEUTICALS INC. (US) | 2015-09-29 | — | — | US | disclosed |
| US-20150252043-A1 | HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES | CITIBANK, N.A., AS ADMINISTRATIVE AGENT | 2015-09-10 | — | — | US | disclosed |
| US-20140243324-A1 | USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS | LIGAND PHARMACEUTICALS INCORPORATED (US) | 2014-08-28 | — | — | US | disclosed |
| EP-2642994-A2 | USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS | Ligand Pharmaceuticals Incorporated (US) | 2013-10-02 | — | — | EP | disclosed |
| US-20120295904-A1 | HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES | LIGAND PHARMACEUTICALS INC. (US) | 2012-11-22 | — | — | US | disclosed |
| WO-2012068406-A2 | USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS | LIGAND PHARMACEUTICALS INCORPORATED (US) | 2012-05-24 | — | — | WO | disclosed |
| EP-1740584-A1 | FUSED QUINOLINE DERIVATIVE AND USE THEREOF | Takeda Pharmaceutical Company Limited (JP) | 2007-01-10 | — | — | EP | disclosed |
| WO-2005105802-A1 | FUSED QUINOLINE DERIVATIVE AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2005-11-10 | — | — | WO | disclosed |
| EP-0778209-B1 | Oxygen absorbing container | TOYO SEIKAN KAISHA LTD (JP) | 1998-09-09 | — | — | EP | disclosed |
| US-5800887-A | CARBON MONOXIDE-STYRENE OR ETHYLENE COPOLYMER | TOYO SEIKAN KAISHA, LTD. (JP) | 1998-09-01 | — | — | US | disclosed |
| EP-0778209-A1 | Oxygen absorbing container | TOYO SEIKAN KAISHA LIMITED (JP) | 1997-06-11 | — | — | EP | disclosed |
| US-RE35135-E | Dental material; mixture of radical-polymerizable monomer, alpha-ketocarbonyl and aromatic amine | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1995-12-26 | — | — | US | disclosed |
| EP-0136186-B1 | PHOTOCURABLE RESIN COMPOSITION | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1989-09-06 | — | — | EP | disclosed |
| US-4548689-A | RADICAL POLYMERIZABLE MONOMER, KETOCARBONYL COMPOUND AND MERCAPTOB | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1985-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140243324-A1 | USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS | HGF, EPOR, MPL | KDM4D 3944/4885PRSS1 1620/4885TP53 828/4885 |
| US-20150252043-A1 | HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES | MPL, CSF3R, HGF | KDM4D 1645/4885PRSS1 3307/4885TP53 309/4885 |
| US-20120295904-A1 | HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES | MPL, CSF3R, HGF | KDM4D 1645/4885PRSS1 3307/4885TP53 309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.